Medical News

RSS

PhenotypeIT launches integrated Corporate Health and Wellness Management Platform

PhenotypeIT, Inc. announced today the launch of its PhIT™ platform, the first truly integrated Corporate Health and Wellness Management Platform that predicts disease and chronic health conditions before their onset and provides critical aggregated data to employers to reduce costs. The PhIT platform accurately assesses the impact of current and future health conditions, and assesses the cost implications of these conditions and related loss of productivity for the employer.

2 Jul 2010

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Just one year after The University of Texas MD Anderson Cancer Center launched its secured, Web-based portal for personal health information, more than 28,000 patients (57 percent) who logged into myMDAnderson - a personalized, online connection to the center - have accessed their personal medical information, test results and records.

2 Jul 2010

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

Utilizing Fluidigm Corporation's Dynamic Array™ and Digital Array™ integrated fluidic circuits (IFCs), Stanford University researchers to have discovered a much larger spectrum of differences between individual cells than has previously been demonstrated. Among these differences are the communication capabilities that emerge from the interactions of genetic circuitry that mediates cell-to-cell communication.

2 Jul 2010

XenoPort reports equity awards to new employee under Inducement Award Plan

XenoPort, Inc. reported today that equity awards were made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee was granted options to purchase an aggregate of 75,000 shares of XenoPort's common stock and restricted stock units representing an aggregate of 5,000 shares of XenoPort's common stock.

2 Jul 2010

Modified Citrus Pectin holds promise against prostate cancer

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

2 Jul 2010

HMS acquires AMG-SIU for $26.2 million

HMS today announced it has signed a definitive agreement to acquire privately-held Allied Management Group (AMG-SIU), a leading provider of fraud, waste, and abuse prevention and detection solutions for healthcare payors, in an all-cash transaction. AMG-SIU is based in Santa Ana, California.

2 Jul 2010

HMS purchases $9.8M building in Irving, Texas

HMS today announced it has purchased the building in Irving, Texas where a majority of HMS's employees are located. The purchase price was $9.8 million.

2 Jul 2010

First Edition: July 2, 2010

Today's health policy headlines include the latest developments regarding Virginia's legal challenge to the federal health care overhaul.

2 Jul 2010

Two questions to identify families whose young children suffer from hunger

Asking parents just two simple screening questions could help health care providers and social workers to easily and quickly identify families whose young children are suffering from hunger, enabling early interventions that could prevent serious health consequences, according to a new study led by University of Maryland School of Medicine researchers. The study, published July 1 in the journal Pediatrics, analyzed data gathered from more than 30,000 families nationwide, about a quarter of whom suffered from hunger.

2 Jul 2010

MedAptus awarded U.S. patent for "Method and System for Processing Medical Billing Records"

MedAptus®, the market leader in charge capture technologies, announced today that it has been awarded U.S. patent number 7,685,002 entitled "Method and System for Processing Medical Billing Records." The patent pertains to MedAptus' automated process for completely and accurately capturing both professional and facility charges in outpatient settings.

2 Jul 2010

Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients

Shire plc, the global specialty biopharmaceutical company, today announced positive data from its long-term extension to its open label Phase I/II study (TKT-025 EXT) for VPRIV® (velaglucerase alfa), the company's enzyme replacement therapy for patients with type 1 Gaucher disease. The data were presented at the 9th Annual European Working Group on Gaucher Disease (EWGGD) in Cologne, Germany, and add to the growing body of clinical evidence which supports the safety and sustained efficacy of VPRIV.

2 Jul 2010

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

European legislation that requires all couples undergoing assisted reproduction treatment (ART) to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing for patients, the 26th annual meeting of the European Society of Human Reproduction and Embryology heard Monday.

2 Jul 2010

Imaging algorithm distributed in top-down fashion reduces unnecessary cervical spine radiographs

An imaging algorithm produced by a radiology department and distributed through the medical director's office, in a top-down fashion, enabled a large, academic medical center to significantly reduce the number of unnecessary cervical spine radiographs (X-rays) in the emergency department, according to a study published in the July issue of the Journal of the American College of Radiology.

2 Jul 2010

Sensor-augmented insulin-pump therapy effective for type 1 diabetes patients

Adding a continuous blood sugar level sensor to an insulin pump helps patients with type 1 diabetes achieve better blood sugar control compared to the common standard of care, multiple daily insulin injections, concludes a study published on-line today in the New England Journal of Medicine.

2 Jul 2010

Columbia Laboratories shareholders approve Watson's aquisition terms

Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia's CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

2 Jul 2010

Twelve type 2 diabetes susceptibility loci identified

An international team co-led by scientists from the University of Michigan have discovered 12 more regions on the genome with DNA variants that are associated with increased risk of type 2 diabetes, bringing the number to 38.

2 Jul 2010

IBM, University of Missouri collaborate to develop cloud computing environment for genomics research

IBM and the University of Missouri today announced a life sciences research initiative using IBM high performance computing technologies to advance the school's bioinformatics research projects. The goal of the initiative is to develop a first-of-a-kind cloud computing environment for genomics research collaboration at a regional level.

2 Jul 2010

Clemizole can yield high-level synergy with protease inhibitor class: Research

Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the lab of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole is Highly Synergistic with HCV Protease Inhibitors".

2 Jul 2010

Investment report on Arena Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Arena Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

2 Jul 2010

Suggestions to reduce impact of anesthesia care on global warming

Inhaled anesthetics widely used for surgery—particularly the anesthetic desflurane—make a measurable contribution to global warming, according to a study in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jul 2010

Medical News

PhenotypeIT launches integrated Corporate Health and Wellness Management Platform

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

XenoPort reports equity awards to new employee under Inducement Award Plan

Modified Citrus Pectin holds promise against prostate cancer

HMS acquires AMG-SIU for $26.2 million

HMS purchases $9.8M building in Irving, Texas

First Edition: July 2, 2010

Two questions to identify families whose young children suffer from hunger

MedAptus awarded U.S. patent for "Method and System for Processing Medical Billing Records"

Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

Imaging algorithm distributed in top-down fashion reduces unnecessary cervical spine radiographs

Sensor-augmented insulin-pump therapy effective for type 1 diabetes patients

Columbia Laboratories shareholders approve Watson's aquisition terms

Twelve type 2 diabetes susceptibility loci identified

IBM, University of Missouri collaborate to develop cloud computing environment for genomics research

Clemizole can yield high-level synergy with protease inhibitor class: Research

Investment report on Arena Pharmaceuticals

Suggestions to reduce impact of anesthesia care on global warming

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News